Pharma News

Piramal Imaging pleased to support study on assessing value of PET scans in Alzheimer’s disease and Dementia Diagnosis

  • Posted on: 25 April 2015
  • By: Shalini.Sharma

Piramal Imaging is honoured to announce it will provide funding and support, along with other industry partners, for a major clinical study titled, "Imaging Dementia – Evidence for Amyloid Scanning" (IDEAS). The trial is designed to evaluate the impact of positron emission tomography (PET) scanning of beta-amyloid deposits in the diagnosis of Alzheimer’s disease (AD) and Dementia in a defined patient population.

Merck Collaborates with Maharashtra University to Build Diabetes and Hypertension Healthcare Capacity India

  • Posted on: 23 April 2015
  • By: PharmaTutor News

Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, in collaboration with Maharashtra University of Health Sciences and Directorate of Medical Education & Research is introducing European Accredited Clinical Diabetes management for more than 5000 medical students in 18 medical colleges of Maharashtra University as part of Merck Capacity Advancement Program (CAP) in Asia.

Health Ministry launched new system to take action related to non-availability and overcharging of medicines

  • Posted on: 22 April 2015
  • By: PharmaTutor News

All essential medicines specified in the National List of Essential Medicines, 2011 (NLEM) are included in the First Schedule of DPCO, 2013 and are under price control. However, Life saving drugs are not defined in the Drugs (Price Control) Order, 2013.

Sandoz generic Copaxone get US FDA approval for to treat relapsing forms of multiple sclerosis

  • Posted on: 22 April 2015
  • By: Shalini.Sharma

Sandoz, a global leader in generic pharmaceuticals and a  subsidiary of Novartis, has received approval from the US Food and Drug Administration (FDA) for Glatopa. Glatopa is the first FDA-approved, substitutable generic version of Copaxone® 20mg, a treatment for relapsing forms of multiple sclerosis. Sandoz, together with Momenta, is proud to be the first company to receive FDA approval for a substitutable generic version of this important therapy.

Bacteria use magnetic particles to create 'natural battery'

  • Posted on: 22 April 2015
  • By: admin

Bacteria can use tiny magnetic particles to effectively create a 'natural battery', a new study has found. The bacteria can load electrons onto and discharge electrons from microscopic particles of magnetite, researchers said. This discovery holds out the potential of using this mechanism to help clean up environmental pollution, and other bioengineering applications, they said.

Pages